lupin

  1. K

    February 26 Market Update: Key Stocks and Corporate Developments

    SBI Life Insurance Declares Interim Dividend for FY26 SBI Life Insurance has announced an interim dividend of ₹2.70 per equity share for the financial year 2025 to 26. Shareholders whose names appear on the record date of March 6, 2026 will be eligible to receive the payout.The company stated...
  2. K

    Lupin Secures USFDA Approval for Generic Brivaracetam Oral Solution, Launches in US Market

    Lupin Receives USFDA Nod for Seizure Treatment Drug Mumbai based pharmaceutical major Lupin Ltd on Wednesday announced that it has received approval from the U.S. Food and Drug Administration to market a generic medication used in the treatment of seizures in the United States.The approval...
  3. K

    Lupin Secures European Commission Approval for Ranluspec Biosimilar to Treat Eye Disorders

    New Delhi, February 23Drug maker Lupin on Monday announced that it has received approval from the European Commission for its biosimilar Ranluspec, used in the treatment of several serious eye conditions.The approval follows a recent positive opinion from the Committee for Medicinal Products...
Back
Top